Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
8.28
-0.29 (-3.38%)
Dec 20, 2024, 4:00 PM EST - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $370.85 million as of December 20, 2024. Its market cap has increased by 24.11% in one year.
Market Cap
370.85M
Enterprise Value
303.81M
1-Year Change
24.11%
Ranking
Category
Stock Price
$8.28
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $370.85M, a decrease of -53.45%. That is a compound annual growth rate of -11.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enhabit | 387.19M |
| Alpha Teknova | 385.95M |
| Allogene Therapeutics | 385.80M |
| Nano-X Imaging | 384.49M |
| GH Research | 384.49M |
| Quanterix | 383.41M |
| Taysha Gene Therapies | 379.15M |
| ZimVie | 373.14M |